Uncovering the mechanisms of Acinetobacter baumannii virulence.
Harding CM, Hennon SW, Feldman MF.
Nat Rev Microbiol. 2018 Feb;16(2):91-102. doi: 10.1038/nrmicro.2017.148. Epub 2017 Dec 18.
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.
Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH.
Front Cell Infect Microbiol. 2017 Mar 13;7:55. doi: 10.3389/fcimb.2017.00055. eCollection 2017.
Bacterial co-infections with SARS-CoV-2.
Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi HAA, Jeda AS, Dashtbin S, Jalalifar S, Mohammadzadeh R, Teimoori A, Tari K, Salari M, Ghiasvand S, Kazemi S, Yousefimashouf R, Keyvani H, Karampoor S.
IUBMB Life. 2020 Oct;72(10):2097-2111. doi: 10.1002/iub.2356. Epub 2020 Aug 8.
Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.
McConnell MJ, Actis L, Pachón J.
FEMS Microbiol Rev. 2013 Mar;37(2):130-55. doi: 10.1111/j.1574-6976.2012.00344.x. Epub 2012 Jun 18.
An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation.
Mea HJ, Yong PVC, Wong EH.
Microbiol Res. 2021 Jun;247:126722. doi: 10.1016/j.micres.2021.126722. Epub 2021 Feb 4.
Clinical relevance of the ESKAPE pathogens.
Pendleton JN, Gorman SP, Gilmore BF.
Expert Rev Anti Infect Ther. 2013 Mar;11(3):297-308. doi: 10.1586/eri.13.12.
Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Ibrahim ME.
Ann Clin Microbiol Antimicrob. 2019 Jan 3;18(1):1. doi: 10.1186/s12941-018-0301-x.
Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors.
López-Rojas R, Smani Y, Pachón J.
Expert Rev Anti Infect Ther. 2013 Mar;11(3):231-3. doi: 10.1586/eri.13.11.
Histopathological Analysis of Acinetobacter baumannii Lung Infection in a Mouse Model.
Tansho-Nagakawa S, Sato Y, Ubagai T, Kikuchi-Ueda T, Kamoshida GO, Nishida S, Ono Y.
Pol J Microbiol. 2021 Dec;70(4):469-477. doi: 10.33073/pjm-2021-044. Epub 2021 Dec 23.
Clinical Characteristics of Acinetobacter baumannii Infection in Solid-Organ Transplant Recipients.
Serifoglu I, Er Dedekarginoglu B, Savas Bozbas S, Akcay S, Haberal M.
Exp Clin Transplant. 2018 Mar;16 Suppl 1(Suppl 1):171-175. doi: 10.6002/ect.TOND-TDTD2017.P51.
